NCT05954390View on ClinicalTrials.gov

The Effect of LentinexHP® on Quality of Life in Stage IV Colorectal Cancer

NAUnknownINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

May 20, 2023

Primary Completion Date

September 30, 2024

Study Completion Date

December 31, 2024

Conditions
Change in MoodChange in Personality
Interventions
DIETARY_SUPPLEMENT

Undenatured beta-glucan solution

The active comparator is a solution containing undenatured beta-glucans

OTHER

Placebo

The placebo comparator is the same solution as the active therapy except it does not contain any undenatured beta-glucans

Trial Locations (1)

Unknown

RECRUITING

CLINECA EAD Hospital, Haskovo

Sponsors

Collaborators (1)

OPIS USA
All Listed Sponsors
collaborator

OPIS USA

OTHER

lead

GlycaNova AS

INDUSTRY